TC
Terrie Curran (President and Chief Executive) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $956K of ARQT (38,200 sh across 2 lots, as filed), executed Aug 27. Data as of Nov 7 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$956K
shares × price, as filed
Last traded
Aug 27
Filed Aug 28
Median ADV $51.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $1.1M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
ARQTRecent filings
ARQTSALE
Arcutis Biotherapeutics, Inc.
View filing →
$956K38,200 sh across 2 lots
Exec Aug 27
Filed Aug 28 · 5:40 PM ET PHATSALE Phathom Pharmaceuticals, Inc. View filing → $126K
19,109 sh × $6.59
Exec Jan 21 2025
Filed Jan 23 2025 · 5:30 PM ET